Home/Sensorion/Karine Lignel
KL

Karine Lignel

Chief Financial Officer

Sensorion

Sensorion Pipeline

DrugIndicationPhase
OTOF-GT (SENS-501)Otoferlin Deficiency (Auditory Neuropathy)Phase 1/2
GJB2-GTEarly Presbycusis linked to GJB2Preclinical
SENS-401Hearing Preservation after Cochlear ImplantationPhase 2